Urea Cycle Disorders Treatment Market is less competitive than other healthcare markets

Urea Cycle Disorder (UCD) is a collection of uncommon genetic diseases that affects 3,000 to 7000 persons in the United States each year. UCD is caused by a genetic mutation that causes insufficiency of one or more of the urea cycle's six key enzymes. The urea cycle is a series of biochemical events in which one of the waste products of protein metabolism (nitrogen) is eliminated from the bloodstream and gradually transformed into urea. Finally, urea in the blood is excreted from the body through urine. Nitrogen accumulates in UCD in the form of ammonia, an extremely harmful toxin for the body.It leads to a dangerous disease known as hyperammonia (elevated levels of ammonia in blood). If ammonia penetrates the brain cells through the bloodstream, it can cause unconsciousness, irreversible brain damage, or death in catastrophic cases.



According to CDC (Centers for Disease Control and Prevention) data, UCD is expected to affect 1 in every 8500 newborns. According to research, a large number of cases with UCD go undetected. In certain situations, a newborn with UCD dies before a definitive diagnosis can be made. The global prevalence of such situations is either underestimated or unknown. Some European scientists believe that incidences of Sudden Infant Death Syndrome (SIDS) are caused by aN unknown inborn error of metabolism, for example, UCD. In the coming years, these conditions are expected to drive the urea cycle disorders therapy market. Furthermore, the worldwide urea cycle disorders treatment market is expected to be driven by research & development initiatives performed by research & academic institutes backed by pharmaceutical firms as well as governments. As a result, a lack of diagnostic and treatment alternatives, as well as a lack of experienced staff and reimbursement policies in developing countries, are some of the factors impeding the global urea cycle disorders treatment market's growth. Because UCD is a rare condition for which no conclusive research has been undertaken, the UCD treatment market is less competitive than other markets. Governments and pharmaceutical businesses must raise market awareness, and coordinated measures must be used.

The global urea cycle disorders treatment market can be segmented by treatment type, enzyme deficiency type, delivery methods, and geography. The global urea cycle disorders therapy market may be divided into amino acid formulas, phenylbutyrate, sodium benzoate, and others based on treatment type. The global urea cycle disorders therapy market is divided into Carbamyl Phosphate Synthetase (CPS1), N-Acetylglutamate Synthetase (NAGS), Ornithine Transcarbamylase (OTC Deficiency), Argininosuccinic Acid Synthetase (AS), Argininosuccinate Lyase (AL or ASA Lyase), Arginase (AG).

The global urea cycle disorders treatment market may be divided into three categories based on delivery channel: hospital pharmacies, retail pharmacies, and online pharmacies.


The global market for urea cycle disorders therapy can be divided into five regions: North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Because of the region's well-developed health-care system, proper reimbursement scenario, and acceptance of cutting-edge procedures, the urea cycle disorders treatment market in North America is expected to grow substantially in the coming years. Following North America, the urea cycle disorders therapy market is expected to grow in Europe and Asia Pacific. Existence of well-established competitors, increased spending in research and development by pharmaceutical behemoths, and collaboration between pharmaceutical and biotech businesses and research institutes are some of the market's key drivers.

Horizon Pharma plc, Lucane Pharma, Recordati Rare Diseases Inc., and Synlogic are among the leading companies in the urea cycle disorders treatment industry.

Comments

Post a Comment

Popular posts from this blog

One of the primary factors driving the Worldwide Frosting and Icing Market is the rising demand for cakes and pastries.

Image
  Market Dynamics The increased demand for cakes and pastries is one of the key reasons driving the global frosting and icing market . According to Agriculture and Agri-Food Canada, the value of cakes sold in the United Kingdom increased by an average of 2% every year from 2012 to 2017, outpacing the CAGR by 1.5 percent (2007-2012). Furthermore, an increase in the number of bakeries as a result of increased urbanisation and rising income, which leads to a burgeoning food sector, is fueling the expansion of the frosting and icing market. In 2015, India's food processing business was valued at US$ 258 billion, according to the India Brand Equity Foundation (IBEF), ranking fifth in terms of consumption, output, and exports. Health issues, such as increased obesity, are, however, restraining market growth. In 2017, 36.5 percent of adults in the United States were obese, according to the Centers for Disease Control and Prevention (CDC), which impeded market expansion. To tackle this, a ...
Read more

Orthopedic Power Tools Market predicted to be growing at a CAGR of 3.50 percent over the forecast period (2020-2027)

Image
Various orthopaedic illnesses in the musculoskeletal systems, such as musculoskeletal trauma, spine diseases, musculoskeletal injuries, and infections, are treated by orthopaedics. Orthopedic power tools are lightweight, user-friendly, and easy to handle when performing orthopaedic surgery when compared to traditional heavy orthopaedic tools. Electric powered orthopaedic tools, battery operated power systems, and pneumatic power tools are the three types of orthopaedic power tools. In 2020, the global orthopaedic power tools market is predicted to be worth US$ 943.8 million, growing at a CAGR of 3.50 percent over the forecast period (2020-2027). One of the reasons predicted to drive market expansion during the forecast period is the rising frequency of spinal injuries. According to a report issued by the National Spinal Cord Injury Statistical Center in 2018, the incidence of spinal cord injury in the United States is roughly 54 instances per one million individuals, with around 17,70...
Read more

The Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market will continue to increase as the number of ambulatory individuals seeking treatment for skin and skin structure infections rises

Image
Acute Bacterial Skin and Skin Structure Infections (ABSSSI) are infections of the epidermis, dermis, and subcutaneous tissues that affect the skin and soft tissues. ABSSSI is defined by the US FDA as lesions having cellulitis/erysipelas, wound infections, and large cutaneous abscesses with a surface area of at least 75 cm2. ABSSSI is caused by pathogens such as Methicillin-sensitive Staphylococcus aureus (MSSA), Methicillin-resistant Staphylococcus aureus (MRSA), Beta-hemolytic Streptococcus, E. coli, Enterococcus faecalis, and Pseudomonas aeruginosa. The rising incidence of drug-resistant strains, particularly in Staphylococcus spp. and Enterococcus spp., makes this infection challenging to treat. The ABSSSI market is predicted to grow at a steady pace, thanks to an increasing number of patients suffering from these conditions and a significant number of pipeline treatments expected to be authorised during the forecast period. Acute Bacterial Skin and Skin Structure Infections (ABSSSI...
Read more